// App-Quantinova.ai

BSH2020‐PO‐204 : Outcomes of Allografts for Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients Aged over 60 years and over 65 years are not inferior to those of younger patients: a single centre study

Researchers

Presenter

  • L. Burgess

Principal Investigators

  • R. Radia

  • G. Errico

  • P. Nelson

  • J. Byrne

Medical Centers

  • Medicine, Nottingham University

  • Oncology, Nottingham University Hospital, Nottingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

  • Acute myelocytic leukemia

Biomarkers

  • Hematocrit

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved